CVS Health Corporation (CVS)
NYSE: CVS · IEX Real-Time Price · USD
59.57
-0.34 (-0.57%)
At close: Jul 19, 2024, 4:00 PM
59.02
-0.55 (-0.92%)
Pre-market: Jul 22, 2024, 7:40 AM EDT
CVS Health Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for CVS Health stock have an average target of 76.1, with a low estimate of 58 and a high estimate of 100. The average target predicts an increase of 27.75% from the current stock price of 59.57.
Analyst Consensus: Buy
* Price targets were last updated on Jun 12, 2024.
Analyst Ratings
The average analyst rating for CVS Health stock from 21 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 13 | 13 | 12 | 8 | 8 | 8 |
| Hold | 3 | 4 | 4 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 23 | 22 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $58 | Hold | Reiterates | $58 | -2.64% | Jun 12, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $101 → $86 | Buy | Maintains | $101 → $86 | +44.37% | May 30, 2024 |
| Baird | Baird | Hold Initiates $61 | Hold | Initiates | $61 | +2.40% | May 30, 2024 |
| Argus Research | Argus Research | Strong Buy Maintains $100 → $80 | Strong Buy | Maintains | $100 → $80 | +34.30% | May 8, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $76 → $60 | Hold | Maintains | $76 → $60 | +0.72% | May 7, 2024 |
Financial Forecast
Revenue This Year
372.45B
from 357.78B
Increased by 4.10%
Revenue Next Year
390.91B
from 372.45B
Increased by 4.96%
EPS This Year
7.10
from 6.47
Increased by 9.71%
EPS Next Year
7.93
from 7.10
Increased by 11.70%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 392.7B | 428.4B | 474.3B | 476.1B | 476.2B |
| Avg | 372.5B | 390.9B | 414.7B | 436.9B | 456.5B |
| Low | 354.8B | 369.3B | 389.0B | 411.7B | 441.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.8% | 15.0% | 21.3% | 14.8% | 9.0% |
| Avg | 4.1% | 5.0% | 6.1% | 5.4% | 4.5% |
| Low | -0.8% | -0.9% | -0.5% | -0.7% | 1.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.43 | 9.60 | 10.78 | 10.71 | 11.71 |
| Avg | 7.10 | 7.93 | 8.90 | 9.73 | 10.60 |
| Low | 6.37 | 7.37 | 7.58 | 9.04 | 9.82 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 30.3% | 35.2% | 36.0% | 20.4% | 20.3% |
| Avg | 9.7% | 11.7% | 12.2% | 9.3% | 9.0% |
| Low | -1.5% | 3.8% | -4.4% | 1.6% | 0.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.